168 related articles for article (PubMed ID: 30175246)
21. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) A randomised, placebo-controlled trial.
Williams-Johnson JA; McDonald AH; Strachan GG; Williams EW
West Indian Med J; 2010 Dec; 59(6):612-24. PubMed ID: 21702233
[TBL] [Abstract][Full Text] [Related]
22. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.
WOMAN Trial Collaborators
Lancet; 2017 May; 389(10084):2105-2116. PubMed ID: 28456509
[TBL] [Abstract][Full Text] [Related]
23. HALT-IT--tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial.
Roberts I; Coats T; Edwards P; Gilmore I; Jairath V; Ker K; Manno D; Shakur H; Stanworth S; Veitch A
Trials; 2014 Nov; 15():450. PubMed ID: 25409738
[TBL] [Abstract][Full Text] [Related]
24. Tranexamic acid in traumatic brain injury: an explanatory study nested within the CRASH-3 trial.
CRASH-3 Intracranial Bleeding Mechanistic Study Collaborators
Eur J Trauma Emerg Surg; 2021 Feb; 47(1):261-268. PubMed ID: 32076783
[TBL] [Abstract][Full Text] [Related]
25. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
HALT-IT Trial Collaborators
Lancet; 2020 Jun; 395(10241):1927-1936. PubMed ID: 32563378
[TBL] [Abstract][Full Text] [Related]
26. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
; Shakur H; Roberts I; Bautista R; Caballero J; Coats T; Dewan Y; El-Sayed H; Gogichaishvili T; Gupta S; Herrera J; Hunt B; Iribhogbe P; Izurieta M; Khamis H; Komolafe E; Marrero MA; Mejía-Mantilla J; Miranda J; Morales C; Olaomi O; Olldashi F; Perel P; Peto R; Ramana PV; Ravi RR; Yutthakasemsunt S
Lancet; 2010 Jul; 376(9734):23-32. PubMed ID: 20554319
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of time to treatment estimates in the CRASH-3 clinical trial: impact on the trial results.
Mansukhani R; Frimley L; Shakur-Still H; Sharples L; Roberts I
Trials; 2020 Jul; 21(1):681. PubMed ID: 32711551
[TBL] [Abstract][Full Text] [Related]
28. The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial.
Estcourt LJ; McQuilten Z; Powter G; Dyer C; Curnow E; Wood EM; Stanworth SJ;
Trials; 2019 Oct; 20(1):592. PubMed ID: 31615553
[TBL] [Abstract][Full Text] [Related]
29. Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: study protocol for an international, randomised, double-blind, placebo-controlled trial.
Ker K; Roberts I; Chaudhri R; Fawole B; Beaumont D; Balogun E; Prowse D; Pepple T; Javaid K; Kayani A; Arulkumaran S; Bates I; Shakur-Still H;
Trials; 2018 Dec; 19(1):712. PubMed ID: 30594227
[TBL] [Abstract][Full Text] [Related]
30. A cost-effectiveness and value of information analysis to inform future research of tranexamic acid for older adults experiencing mild traumatic brain injury.
Williams J; Ker K; Roberts I; Shakur-Still H; Miners A
Trials; 2022 May; 23(1):370. PubMed ID: 35505387
[TBL] [Abstract][Full Text] [Related]
31. Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: Statistical analysis plan for the WOMAN-2 trial: an international, randomised, placebo-controlled trial.
Collier T; Shakur-Still H; Roberts I; Balogun E; Olayemi O; Bello FA; Chaudhri R; Muganyizi P;
Gates Open Res; 2023; 7():69. PubMed ID: 37664793
[No Abstract] [Full Text] [Related]
32. [Should all patients with traumatic brain injury receive tranexamic acid?].
Rostami E; Kongstad P; Marklund N
Lakartidningen; 2020 Oct; 117():. PubMed ID: 33021328
[TBL] [Abstract][Full Text] [Related]
33. Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial.
Yutthakasemsunt S; Kittiwatanagul W; Piyavechvirat P; Thinkamrop B; Phuenpathom N; Lumbiganon P
BMC Emerg Med; 2013 Nov; 13():20. PubMed ID: 24267513
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial.
Roberts I; Prieto-Merino D; Manno D
Crit Care; 2014 Dec; 18(6):685. PubMed ID: 25498484
[TBL] [Abstract][Full Text] [Related]
35. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
[TBL] [Abstract][Full Text] [Related]
36. Antifibrinolytics in the treatment of traumatic brain injury.
Schober P; Loer SA; Schwarte LA
Curr Opin Anaesthesiol; 2022 Oct; 35(5):583-592. PubMed ID: 35900731
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury: the Eurotherm3235 RCT.
Andrews PJ; Sinclair HL; Rodríguez A; Harris B; Rhodes J; Watson H; Murray G
Health Technol Assess; 2018 Aug; 22(45):1-134. PubMed ID: 30168413
[TBL] [Abstract][Full Text] [Related]
38. Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury.
Presneill J; Little L; Nichol A; French C; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R; ;
Trials; 2014 Dec; 15():501. PubMed ID: 25528574
[TBL] [Abstract][Full Text] [Related]
39. Trauma and severe bleeding. Tranexamic acid within one hour to reduce mortality.
Prescrire Int; 2013 Jul; 22(140):189-90. PubMed ID: 23951599
[TBL] [Abstract][Full Text] [Related]
40. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
